Remyelination in Multiple Sclerosis: a PET-MR longitudinal study investigating individual profiles of myelin repair and the contribution of neuroinflammation (SMART in MS)
APHP200056
Phase 3 other active
Quick answer
Remyelination in Multiple Sclerosis: a PET-MR longitudinal study investigating individual profiles of myelin repair and the contribution of neuroinflammation (SMART in MS) for Remyelination in Multiple Sclerosis is a Phase 3 program (other) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Remyelination in Multiple Sclerosis
- Phase
- Phase 3
- Modality
- other
- Status
- active